MDWD
NASD MediWound Ltd.$12.42 ↑ +0.00 (+0.00%) Trading Up from the previous close of $12.42, $0.69 below the day’s high of $13.11
- YTD change
- -32.72%
- vs 20-day SMA
- -8.29%
- vs 200-day SMA
- -21.09%
Price ranges
Price & Performance
-4.85 (-28.08%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 48.2% away from all-time highs of $24.00
- MDWD is down 33% since the beginning of the year
- MDWD is down 30% over the past 12 months
- MDWD is down 10% over the past 1 month
- 20% of all MDWD investors are betting against MDWD
MDWD reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -29.5%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -9.80%
- vs 8-day SMA
- -8.11%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.